Trials / Completed
CompletedNCT04922814
Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Many questions about management of COVID-19 are still not answered. So, we recruit this study aiming to evaluate improvement of oxygenation in COVID-19 patients with severe ARDS, to improve morbidity and mortality of ICU covid patients, to participate in understanding of real hidden pathophysiology of COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | muscle relaxation | They will receive muscle relaxation treatment for at least 48 hours. Cisatracurium will be given. Short term infusions up to 24 hours will be given in a dose rate of 2-3 mic/Kg/min followed by intervallic shots of 2-5 mg. |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-03-01
- Completion
- 2022-08-01
- First posted
- 2021-06-11
- Last updated
- 2025-12-24
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04922814. Inclusion in this directory is not an endorsement.